Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Cancer Res. 2017 Aug 30;77(21):5808–5819. doi: 10.1158/0008-5472.CAN-16-2524

Figure 3. GA-hMSC-derived exosomes enhance GSC tumorigenicity in vivo.

Figure 3

(A,B) Survival curves showing a significant (p<0.05, log-rank test) decrease in median survival for GSC tumor bearing mice which were pre-treated with matched GA-hMSC-derived exosomes prior to implantation. Median survial was 45 days for GSC-262 (A) and 37 days for GSC-20 (B). (C,D) H&E staining of mice brain tumor sections demonstrating a significant (p<0.05, paired t-test) increase in tumor volume at 40 days. Arrows indicate tumor location. CM-conditioned media, ED-CM-exosome depleted-conditioned media.